Twin Tree Management’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-8,600
Closed -$2.11M 1597
2022
Q3
$2.11M Sell
8,600
-7,700
-47% -$2.08M ﹤0.01% 938
2022
Q2
$4.03M Sell
16,300
-800
-5% -$216K 0.01% 905
2022
Q1
$5.66M Buy
+17,100
New +$5.26M 0.01% 877
2019
Q3
Sell
-15,500
Closed -$4.04M 1582
2019
Q2
$4.04M Sell
15,500
-28,000
-64% -$7.43M 0.02% 508
2019
Q1
$12.4M Buy
43,500
+42,300
+3,525% +$14.1M 0.06% 248
2018
Q4
$390K Sell
1,200
-900
-43% -$313K ﹤0.01% 1006
2018
Q3
$944K Buy
+2,100
New +$828K 0.01% 732
2018
Q1
Sell
-10,700
Closed -$2M 1368
2017
Q4
$2M Sell
10,700
-37,300
-78% -$6.96M 0.01% 587
2017
Q3
$8.09M Buy
48,000
+10,700
+29% +$1.62M 0.06% 275
2017
Q2
$5.34M Buy
+37,300
New +$5.01M 0.04% 369
2017
Q1
Sell
-17,000
Closed -$1.92M 1333
2016
Q4
$1.92M Sell
17,000
-20,300
-54% -$2.35M 0.02% 631
2016
Q3
$4.8M Buy
+37,300
New +$4.47M 0.06% 290

Other funds holding ABMD

Twin Tree Management's ABMD Position: Q3 2022 in Review

Twin Tree Management sold out of Abiomed Inc (ABMD) in Q3 2022, closing a stake of 11,827 shares — an estimated $3.19M sold.

Twin Tree Management first reported a position in ABMD in Q4 2016 and held it in 11 quarters. The position peaked at $9.72M in Q1 2019. 517 funds tracked by Wall St. Rank hold ABMD as of Q3 2022.

  • Twin Tree Management reported no remaining Abiomed Inc position as of Q3 2022 after selling out during the quarter.
  • Twin Tree Management sold 11,827 Abiomed Inc shares in Q3 2022, an estimated $3.19M.
  • Twin Tree Management first reported a position in Abiomed Inc in Q4 2016 and held it in 11 quarters.
  • Twin Tree Management's Abiomed Inc position peaked at $9.72M in Q1 2019.
  • 517 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2022.

Based on Twin Tree Management's 13F filing for Q3 2022, filed 10 Nov 2022.